Teens Are Four Times More Likely to Smoke When Parents Do

MarketInnovation
Jul.21.2022
Top medical experts have warned that teens whose parents or primary caregivers smoke, are four times more likely to take up smoking than than their peers whose parents do not.

UK government campaign titled “Better Health Smoke Free” aims to educate adult smokers about how their habit can influence younger people to take up smoking.

Teens Are Four Times More Likely to Smoke When Parents Do

A new campaign released by the UK government titled “Better Health Smoke Free” aims to educate on how adult smokers can influence younger people to take up the habit. Featuring a number of experts on the topic, the Better Health Smoke Free campaign explains that research has shown that teens whose primary caregiver smoked were more than twice as likely to have tried cigarettes (26% vs 11% ) and four times as likely to be a regular smoker (4.9% vs 1.2%).

 

In a film released last year, the NHS and behavioural health experts discussed the link between smoking parents and the subsequent likelihood of their children to smoke. The speakers included GP Dr Nighat Arif, child psychologist Dr Bettina Hohnen, and smoking cessation experts Professor Nick Hopkinson and Dr Anthony Laverty of Imperial College London, who urged parents to act as positive role models by quitting smoking.

 

Parliamentary Under Secretary of State and Minister for Vaccines and Public Health, Maggie Throup MP, added that now a particularly good time to give up smoking is the new year. “We know that many people make a quit attempt in January, and while there are so many good reasons to stop smoking for yourself, we hope that this new campaign – by highlighting the inter-generational smoking link with parents influencing their children – will be the added motivation many need to ditch the cigarettes for good this year,” she said.

 

“With so much help and support available for parents, carers and anyone looking to quit – including the NHS Quit Smoking app, support on Facebook, daily emails and texts, and an online Personal Quit Plan – you won’t be alone in your New Year’s resolution.”

 

Pregnant women should be offered financial incentives

 

In other news, the Royal College of Physicians (RCP) said that pregnant women who are unable to quit smoking should be offered financial incentives to help them achieve the goal. The RCP said that at any point of contact with the NHS, smokers should be provided with “opt-out smoking cessation services.” Moreover, said the group, bearing in mind that most smokers are often from “lower socio-economic groups”, pregnant women should be given financial incentives to motivate them in achieving the goal.

 

These suggestions were put forward as part of a report compiled by the RCP, addressing what can be done to achieve the government’s “Smoke Free 2030” target. Sadly recent data has indicated that as it stands the goal will not actually be achieved until 2050.

 

“The ability of the UK and other countries to rise to major public health challenges is beyond doubt; the Covid-19 pandemic, by far the biggest new challenge to UK and global health in decades, has attracted a public health and economic response of a scale unique in the modern era,” read the report. “Yet in 2020, when Covid-19 killed around 80,000 UK citizens, tobacco smoking killed 94,000.”

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26